To reveal the clinical relevance of current study, we performed several feasible analyses of the expression profiles of SRC‐1, IRF1, and PD‐L1 in tumors or paracancerous tissues of 36 CRC patients. The gene discussed is IRF1; the disease is colorectal carcinoma.